We obtained neutralizing monoclonal antibodies against a continuous neutralization epitope on VP2 of poliovirus type 1 strain Mahoney by using a combined in vivo-in vitro immunization procedure. The antibody-binding site was mapped to amino acid residues within the peptide segment (residues 164 through 170) of VP2 by competition with synthetic peptide and sequencing of resistant mutants. Cross-neutralization of these mutants with another neutralizing monoclonal antibody revealed a linkage of the continuous epitope and a discontinuous neutralization epitope involving both loops of the double-loop structure of VP2 at the twofold axis on the surface of the virion.
The characterization of antigenic structures of animal viruses at the molecular level has made great progress in the last few years. Especially in the picornavirus group the use of neutralizing monoclonal antibodies (MAbs) and rapid sequencing techniques of RNA genomes of neutralizationresistant mutants have been valuable tools for the mapping of neutralization sites (2, 7, 21-23, 25, 29, 40, 41) . These results in context with the known three-dimensional structure of several members of the picornavirus group provided a detailed, although certainly still incomplete, picture of viral surface structures involved in a specific immune response (16, 27) . The limitations are probably due to the small number of MAbs and to the screening and selection procedures used. In general, three to four neutralizing antigenic sites have been described, involving residues of all three major polypeptides. The existence of neutralization sites on the three major polypeptides of poliovirus type 1 was first demonstrated by immunization of rabbits with purified polypeptides (6) .
The sites recognized by murine MAbs have been mapped to amino acid residues 91 through 101 of VP1 (N-AgI, site 1) and to residues 221 through 226 of VP1 and 164 through 170 and 270 of VP2 (N-AgII, site 2). N-AgIII, site 3, was mapped to amino acids 58 through 60 and residues 70 through 73 and residues 76, 77, and 79 of VP3 and to residues 286 through 290 of VP1, respectively (7, 21-23, 25, 40-42) . During these studies, an apparent immunodominance of site 1 over sites 2 and 3 in serotypes 2 and 3 was suggested despite the close structural relationship of poliovirus serotypes. This paradox has been attributed to the restricted immune response of inbred mouse strains and to the subtle structural differences of serotypes 1 and 3 at this site (17) . However, using the same mouse strains, we have shown recently that site 1 of poliovirus type 1 is immunogenic by using conventional immunization protocols (33, 40) . Moreover, we described the molecular basis for the linkage of a continuous and a discontinuous epitope involving this site of poliovirus type 1 (41) .
In the present study, we describe the linkage of a new continuous and discontinuous neutralization epitope formed * Corresponding author.
by residues of VP2 of poliovirus type 1. Both neutralizing MAbs recognizing either the continuous or the discontinuous epitope were obtained after combined in vivo-in vitro immunization (39) . Previously, this procedure resulted in the isolation of hybridomas secreting neutralizing MAbs against the continuous epitope within site 1 of poliovirus type 1 (38) . Neutralizing MAbs reacting with isolated polypeptides, thus recognizing continuous neutralization epitopes, are very rare among picornaviruses. To our knowledge, the two cases described in the literature include one antibody against an epitope also within site 1 of poliovirus type 1 and another antibody against an epitope between residues 153 and 164 of VP2 of human rhinovirus 2 (1, 31, 35) . However, a combination of antibodies directed against continuous and discontinuous epitopes within the same site may become very useful for the detection of structural changes of virus particles.
MATERIALS AND METHODS
Growth of virus and cells. Poliovirus type 1 strain Mahoney was propagated in HeLa S3 cells and purified as described previously (8) . The Sabin strain of poliovirus type 1 (Lsc2ab) was grown in suspension cultures of HeLa Ohio cells (Flow Laboratories, Inc., McLean, Va.). Infected cells were harvested after 8 h at 35°C. Cells were lysed by one cycle of freezing and thawing and Dounce homogenization. Cellular debris was removed by low-speed centrifugation. The supernatant was treated with 0.5% sodium deoxycholate and clarified by centrifugation for 10 min at 10,000 x g. From this supernatant, which was adjusted to 0.3 M NaCl and treated with 1% sarcozyl, virus was pelleted by high-speed centrifugation and further purified by cesium chloride density gradients. Virus-containing fractions were stored at -20°C. Virus was pelleted from the fractions by high-speed centrifugation for isoelectric focusing (IEF) and preparation of RNA. HeLa Ohio cells were also grown as monolayer cells and used for microneutralization tests and for the selection and-propagation of antigenic variants.
Preparation of viral polypeptides for immunization. Pure poliovirus polypeptides were obtained by reversed-phase high-pressure liquid chromatography in 60% formic acid and a gradient of acetonitrile as detailed previously (14 (26) in chloroform to assure tight adherence of the gel. A thin Mylar sheet (0.08 cm) bearing slots was included in the chamber assembly. The gel mixture containing 5% acrylamide, 0.13% N,N'-methylen-bisacrylamide, 9 M urea, and 2% ampholines (pH 3.5 to 10) (LKB Instruments) and 0.03% ammonium persulfate was poured into the chamber, and the chamber was left overnight at room temperature. After the chamber was disassembled, the plate with the adhering gel was placed onto a cooling block of the horizontal slab gel apparatus with a thermostat (Multiphor II; LKB Instruments) with the temperature set at 10°C. Paper electrode strips containing 0.02 N H3PO4 (cathode) and 0.04 N NaOH (anode) were placed on top of the edges of the gel. During pre-electrophoresis (400 V, 30 min), the gel was soaked with 8 M urea, 100 mg of dithiothreitol per ml. Virus samples were dissociated for 1 h at 25°C in 9 M urea and 100 ,ug of RNase A per ml; dithiothreitol (0.5%) was added after 15 min. After sample application, voltage was increased stepwise at 10-min intervals from 50 to 100 to 200 to 400 V. Then power was set to 25 W and focusing was continued for 3,600 Vh. The gel was fixed with 20% trichloroacetic acid and silver stained (15) .
Sequencing b Peptide A (VP2 residues 164 through 170): Cys-Asp-Asn-Asn-Gln-ThrSer-Pro.
c Peptide B (VP1 residues 93 through 104): Cys-Asp-Asn-Pro-Ala-SerThr-Thr-Asn-Lys-Asp-Lys-Leu-Cys. Peptide B was circularized by the two additional cysteines.
d Neutralization titers after addition of rabbit anti-mouse immunoglobulins.
e MAb against N-AgI. Table 1 were tested in competition experiments with a synthetic peptide comprising residues 164 through 170 of VP2 of poliovirus type 1 (peptide A). A similar peptide corresponding to amino acids 167 through 173 of VP2 has been used for the induction of a neutralizing response in rabbits (10) . In addition, this segment of VP2 is part of a surface loop that is exposed near the twofold axis on the surface of the virion (16) . As a control in our experiments we used a peptide representing amino acid residues 93 through 104 of VP1 (peptide B) and a neutralizing MAb (no. 95) directed against this site (N-AgI) (38) . The results of the competition experiments are summarized in (Table 3) . We also included a rabbit antiserum that was raised against peptide A (Table 2 ) coupled to BSA. Both MAbs and also the polyclonal anti-peptide antibodies exhibited a strong specificity for the Mahoney strain. This specificity is due to an amino acid substitution within this peptide segment of VP2 of the Sabin strain. The mutation of nucleotide 1462 (A -> G) in the Sabin strain resulted in a substitution of the asparagine by aspartate in position 165 of VP2 (24) . Mutants 1 and 2, which were selected in the presence of antibody 27.108, were also resistant to antibody 27.165, demonstrating a linkage between the discontinuous epitope and the continuous neutralization epitope. This linkage was also found with mutants 6 to 8 selected by antibody 27.165. Mutants 3 and 4, although still sensitive to monoclonal antibody 27.165, were nevertheless resistant to neutralization by polyclonal anti-peptide antibodies. Although mutations have occurred within the peptide segment representing residues 164 through 170 of VP2, obviously they were tolerated by the MAb. In contrast, the phenotype of mutant 5 was most compatible with a mutation outside of this segment of VP2. Determination of the sequence changes conferring the resistant phenotype of the mutants should provide insight into the molecular basis of the linkage of both epitopes.
Sequence determination of antigenic variants. Before our sequencing analysis, the phenotype of all mutants was analyzed by IEF of their structural polypeptides in comparison with wild-type virus (Fig. 1) . The pattern of the Mahoney and Sabin strains is shown in lanes A and B of Fig. 1 of the Sabin strain are due to amino acid substitutions that resulted from.the 22 point mutations in the three major capsid polypeptides (24) . Mutants 1 through 4 (lanes C through F, respectively) showed no charge alteration of their polypeptides, as compared with wild-type virus. However, mutants 5 through 8 (lanes G through K, respectively) had charge alterations of VP2. Mutant 6 (lane H) also had an altered VP3, which, however, is irrelevant in this context.
The mutation in VP2 of mutant 5 and the results of our previous cross-neutralization tests suggested that the discontinuous epitope must be also formed by residues of VP2. Therefore we first sequenced the RNAs of all mutants through the region encoding for VP2 and, if necessary, also through other parts of the capsid region of the genome (Table  4 and Fig. 2 ).
All amino acid substitutions resulting from point muta- tions of the mutants were found between amino acid residues 165 through 168 of VP2 except for mutant 5. In this case, a point mutation was detected about 70 nucleotides upstream, resulting in a substitution of an asparagine for a histidine at position 142 of VP2. This substitution of the weakly basic histidine by asparagine is also demonstrated by the appropriate charge shift of VP2 of the mutant (Fig. 1) . Sequencing of the RNA encoding for the VP3 region of mutant 6 revealed a substitution of residue 60 of VP3 (Thr > Lys), explaining the charge shift of VP3 of this mutant (Fig. 1) . This substitution (Thr -> Lys) is also found in VP3 of the Sabin strain of poliovirus type 1 (24) .
The substitutions of threonine 168 either by alanine or serine (mutants 3 and 4) were tolerated by antibody 27.165, although both mutants became resistant to anti-peptide antibodies. The question of whether these changes are simply tolerated by the antibody or are outside the combining site is left open at the moment.
DISCUSSION
MAbs. Detailed knowledge of antigenic structures of viral polypeptides, especially of structures involved in the induction of a protective immune response, is of fundamental interest for future vaccine development. Because of its known three-dimensional structure, poliovirus type 1 is one of the best-suited candidates for structural and immunologic analysis among naked animal viruses. For the study of antigenic structures of poliovirus polypeptides contributing to antigenic sites either on the mature virion or only on isolated polypeptides and immature precursor particles, it seemed useful to us to raise a panel of MAbs by using isolated structural polypeptides as immunogens. After immunization with VP1 in our in vivo system we obtained antibodies from 19 hybridomas. These antibodies neither neutralized virus nor bound to virus particles. In contrast, after immunization with VP2, all eight hybridomas selected and propagated secreted antibodies that bound to virus particles but also failed to neutralize virus. In addition, the antibodies against VP1 were directed against different parts of the polypeptide chain determined by their reaction with proteolytic fragments in Western blots, whereas all VP2 antibodies bound to the same fragment after cleavage of VP2 (data not shown). Since in both cases identical screening assays and selection procedures had been applied, we assume that VP2, in contrast to VP1, retained a partial native structure even after separation by reversed-phase highpressure liquid chromatography (14) . An indication for this assumption was provided by the observation that electrophoresis of poliovirus polypeptides in high concentrations of formic acid resulted in an inversion of their mobilities in polyacrylamide gels (13) . Obviously in the in vivo situation this residual structural element of VP2 was predominantly recognized by the immune system.
As shown previously, we could increase the number of specific hybridomas 6-to 20-fold by in vitro stimulation of primed spleen cells (39) . Using this protocol and a refined screening and selection procedure of specific hybridomas, we succeeded in the detection of neutralizing MAbs against a continuous epitope on VP1 (38) . As described in the present study, this procedure resulted also in the detection of neutralizing MAbs against a continuous and a discontinuous epitope on VP2. Apparently in vitro stimulation of primed spleen cells yielded hybridomas that secreted highaffinity antibodies, indicated by increased titers in virusbinding assays and in the appearance of virus neutralization activity. It is likely that during in vitro stimulation of primed spleen cells by virus particles a subset of memory cells recognizing cross-reacting antigens is stimulated, giving rise to these antibody secreting hybridomas. At this point, however, we are quite aware that the number of antibodies is too small to draw definite conclusions regarding the mechanisms underlying our immunization procedures.
Continuous and discontinuous neutralization epitopes. Circumstantial evidence for continuous neutralization epitopes on poliovirus polypeptides was obtained by immunization of animals with isolated polypeptides purified by a variety of different procedures (3, 4, 6, 34, 37) . In some cases, synthetic peptides selected on the basis of hydrophilicity profiles of viral polypeptides were also found to induce a low neutralizing response (5, (9) (10) (11) 43) . Since the determination of the three-dimensional structure, it has become evident that peptides that could induce a neutralizing immune response were parts of loops extending from the conserved P-barrel structure of the individual polypeptides (16) .
A discontinuous neutralization epitope involving the peptide segment of residues 164 through 170 of VP2 of poliovirus type 1 has been described previously (22, 25) . This site on the virus had been defined as N-AgII or site 2 (22, 25, 42 Table 5 ) that also selected for a substitution of residues 270 of VP2 and 223 of VP1 (manuscript in preparation). Mutants selected by this antibody, which was obtained after immunization with infectious virus, were still sensitive to the antibodies described in this paper.
Linkage of the continuous and discontinuous epitopes. In a previous report, we have described a linkage of continuous and discontinuous epitopes involving the loop of residues 96 through 104 (N-AgI) and residues 141 through 152 of VP1 of poliovirus type 1. In analogy to human rhinovirus 14, we have called the discontinuous epitope N-AgIB (41) . In VP2 we have now demonstrated a similar situation. In this case both loops are not separated by 13-strands but rather are parts of a double loop structure with a short intervening a-helix (16) .
At the moment, the discontinuous epitopes both on VP1 and VP2 are characterized by a single mutant, in each case with a single amino acid substitution in the loop adjacent to the continuous epitope. However, both mutations occurred in nonconserved regions between serotypes, indicating a possible role of these sites also in vivo.
It has to be emphasized that the linkage of continuous and discontinuous neutralization epitopes described here and in our previous reports provides the first direct evidence for localization of binding sites of antibodies recognizing discontinuous epitopes (40, 41) . In this case, long-range effects of the mutations on the conformation of their binding sites can be ruled out.
Finally, the combination of antibodies recognizing continuous and discontinuous epitopes within the same site provides us with sensitive probes for monitoring structural changes during virus morphogenesis or after virus-cell interactions. A first example for an application is the stability of the epitopes after the well-known conformational change which accompanies the transition of N to H particles (Table  5) . Evidently during this transition the discontinuous epitopes involving two adjacent loops are readily destroyed.
